The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 128.55
Bid: 129.05
Ask: 129.10
Change: 1.55 (1.22%)
Spread: 0.05 (0.039%)
Open: 127.90
High: 131.00
Low: 126.90
Prev. Close: 127.00
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction - Transaction in Own Shares

18 Nov 2022 12:30

RNS Number : 9434G
Centrica PLC
18 November 2022
 

Correction - Transactions in own shares

 

Centrica plc

18 November 2022

 

This is a restatement of the announcements released on 16 November 2022 at 17:55 under RNS No 6846G and 17 November 2022 at 17:30 under RNS No 8250G. These announcements incorrectly stated that the number of ordinary shares in issue (excluding treasury shares) were 5,906,021,470 and 5,904,768,214 respectively when they should have stated the figures as 5,906,092,136 and 5,904,838,880 respectively.

 

All other details remain unchanged.

 

The full amended text of each respective announcement is shown below.

 

 

 

Transactions in own shares

 

 

Centrica plc

16 November 2022

 

Centrica plc announces that today it purchased (through UBS AG London Branch) 1,754,002 Centrica plc ordinary shares of 6 14/81 pence each at a price of 85.9595 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme (details of which were as announced on 15 November 2022) and effected in accordance with the non-discretionary share repurchase agreement entered into with UBS AG London Branch, as announced on 15 November 2022. 

 

Since 15 November 2022, Centrica has purchased 1,754,002 ordinary shares at a cost (excluding dealing and associated costs) of £1,507,731.35.

 

Following the above purchase, Centrica plc holds 1,754,002 ordinary shares in treasury, and has 5,906,092,136 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by UBS AG London Branch is set out below.

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

UBS AG London Branch

Intermediary Code:

UBSWGB2L

Currency:

GBP

Aggregated information

Date of purchase:

16 November 2022

Number of ordinary shares purchased:

1,754,002

Highest price paid

86.70

Lowest price paid

85.44

Volume weighted average price paid per share (p):

85.9595p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by UBS AG London Branch, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 

http://www.rns-pdf.londonstockexchange.com/rns/9434G_1-2022-11-18.pdf

 

END

 

 

 

Transactions in own shares

 

 

Centrica plc

17 November 2022

 

Centrica plc announces that today it purchased (through UBS AG London Branch) 1,253,256 Centrica plc ordinary shares of 6 14/81 pence each at a price of 86.7502 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme (details of which were as announced on 15 November 2022) and effected in accordance with the non-discretionary share repurchase agreement entered into with UBS AG London Branch, as announced on 15 November 2022. 

 

Since 15 November 2022, Centrica has purchased 3,007,258 ordinary shares at a cost (excluding dealing and associated costs) of £2,594,933.44.

 

Following the above purchase, Centrica plc holds 3,007,258 ordinary shares in treasury, and has 5,904,838,880 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by UBS AG London Branch is set out below.

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

UBS AG London Branch

Intermediary Code:

UBSWGB2L

Currency:

GBP

Aggregated information

Date of purchase:

17 November 2022

Number of ordinary shares purchased:

1,253,256

Highest price paid

88.48

Lowest price paid

85.50

Volume weighted average price paid per share (p):

86.7502p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by UBS AG London Branch, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 

http://www.rns-pdf.londonstockexchange.com/rns/9434G_2-2022-11-18.pdf

 

END

 

Enquiries:

Investors and Analysts T: 01753 494900 E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBPBTTMTMBBMT
Date   Source Headline
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20246:00 pmRNSTransaction in Own Shares
1st May 20246:00 pmRNSTransaction in Own Shares
1st May 20245:00 pmRNSBlock listing Interim Review
1st May 20244:30 pmRNSTotal Voting Rights
30th Apr 20246:00 pmRNSTransaction in Own Shares
29th Apr 20246:00 pmRNSTransaction in Own Shares
26th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20245:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:00 pmRNSNotice of AGM
24th Apr 20246:00 pmRNSTransaction in Own Shares
23rd Apr 20246:00 pmRNSTransaction in Own Shares
22nd Apr 20246:00 pmRNSTransaction in Own Shares
19th Apr 20246:00 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSTransaction in Own Shares
17th Apr 20246:00 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:25 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20241:30 pmRNSDirector/PDMR Shareholding
10th Apr 20246:00 pmRNSTransaction in Own Shares
9th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20245:30 pmRNSDirector Declaration
4th Apr 20246:00 pmRNSTransaction in Own Shares
3rd Apr 20246:00 pmRNSTotal Voting Rights - Replacement
3rd Apr 20246:00 pmRNSTransaction in Own Shares
2nd Apr 20246:25 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSTotal Voting Rights
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:25 pmRNSTransaction in Own Shares
26th Mar 20246:30 pmRNSTransfer of Treasury Shares
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:20 pmRNSAnnual Financial Report 2023
25th Mar 20246:00 pmRNSTransaction in Own Shares
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20246:00 pmRNSTransaction in Own Shares
21st Mar 20246:00 pmRNSTransaction in Own Shares
20th Mar 20246:00 pmRNSTransaction in Own Shares
19th Mar 20246:00 pmRNSTransaction in Own Shares
18th Mar 20246:00 pmRNSTransaction in Own Shares
15th Mar 20246:26 pmRNSTransaction in Own Shares
14th Mar 20246:00 pmRNSTransaction in Own Shares
13th Mar 20246:25 pmRNSTransaction in Own Shares
12th Mar 20246:25 pmRNSTransaction in Own Shares
12th Mar 20245:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.